Researchers at the University of Cambridge have developed a novel vaccine whose key component was designed entirely by AI, now tested in humans for the first time. The goal is a single vaccine effective against all known human coronaviruses and related bat viruses, preemptingpreempting/priːˈɛmptɪŋ/L3预先阻止，先发制人taking action in advance to prevent something from happening or to render it ineffective future pandemics. Traditional vaccines target a specific strain, but viral mutation renders them obsolete, necessitating annual reformulations. AI analyses genetic data from thousands of related viruses to identify conserved features, enabling a broad-spectrumbroad-spectrum/ˌbrɔːd ˈspɛktrəm/L3广谱的，涵盖多种类型的effective against a wide range of organisms or variants, rather than a single specific type vaccine.
Unlike mRNA vaccines, this candidate employs DNA, conferring greater stability and easing storage—critical for regions with limited cold-chain infrastructure. It can be administered via a needle-free high-pressure liquid stream, reducing pain and facilitating rapid deployment. These advantages are secondary to its potential to protect against novel viruses, fundamentally altering pandemic response. Broad-spectrum vaccines could also transform management of influenza and Ebola, where strain-specific approaches have proven inadequate.
The phase 1 trial demonstrated safety and tolerability, stimulating antibodies against diverse sarbecoviruses. Notwithstandingnotwithstanding/ˌnɒtwɪθˈstændɪŋ/L3尽管，虽然（表示让步）in spite of; despite the fact that something is true or has been stated these encouraging results, the induced immune responses were modest, and the durability of protection remains uncertain. Larger efficacy trials are required to ascertain whether the vaccine can prevent infection in real-world settings and to determine if booster doses will be necessary. Consequently, a universal vaccine remains several years from deployment, though the proof of concept is significant.
That said, this study illustrates how AI can expediteexpedite/ˈɛkspɪdaɪt/L3加速，促进（进程或事务）to make a process or action happen more quickly or efficiently design of variant-proof vaccines against future pandemic threats. Analogous approaches could yield universal influenza vaccines, obviating annual strain selection, or broad-spectrum Ebola vaccines circumventing strain-specific limitations. Market analysts anticipate substantial investment from governments and pharmaceutical companies seeking to hedge against future pandemics. Arguably, the integration of AI into vaccine development marks a paradigmparadigm/ˈpærədaɪm/L3范式，典范（指思维或方法的模式）a typical example or pattern of something; a model or framework that shapes thinking or practice shift, accelerating preparedness for emerging infectious diseases.
